Transfusion-associated microchimerism: The hybrid within

Transfusion Medicine Reviews

Volumn 27, Issue 1, 2013, Pages 10-20

  Bloch, Evan M ^a   Jackman, Rachael P ^a   Lee, Tzong Hae ^a   Busch, Michael P ^a  

^a BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN; MITOCHONDRIAL DNA;

ADOPTIVE IMMUNOTHERAPY; ALLOIMMUNIZATION; AMNIOCENTESIS; BLOOD TRANSFUSION; CELLULAR IMMUNITY; FETOMATERNAL TRANSFUSION; FETOPLACENTAL UNIT; GENETIC SCREENING; HLA SYSTEM; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREGULATION; LIMIT OF DETECTION; MICROCHIMERISM; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; REVIEW; TRANSFUSION ASSOCIATED GRAFT VERSUS HOST DISEASE; TRANSFUSION ASSOCIATED MICROCHIMERISM; TRANSPLANTATION;

ANIMALS; AUTOIMMUNE DISEASES; BLOOD TRANSFUSION; CELL LINEAGE; CHIMERISM; FEMALE; FETOFETAL TRANSFUSION; FETOMATERNAL TRANSFUSION; GRAFT VS HOST DISEASE; HUMANS; IMMUNE TOLERANCE; IMMUNOTHERAPY, ADOPTIVE; LEUKOCYTE REDUCTION PROCEDURES; MALE; PREGNANCY; PRENATAL DIAGNOSIS; RISK FACTORS; TRANSPLANTATION CHIMERA; WOUNDS AND INJURIES;

EID: 84872276828     PISSN: 08877963     EISSN: 15329496     Source Type: Journal    
DOI: 10.1016/j.tmrv.2012.08.002     Document Type: Review

References (150)

1. Nelson J.L. Microchimerism in human health and disease. Autoimmunity 2003, 36:5-9.
2. Bianchi D.W. Fetal cells in the mother: from genetic diagnosis to diseases associated with fetal cell microchimerism. Eur J Obstet Gynecol Reprod Biol 2000, 92:103-108.
3. Bianchi D.W. Fetomaternal cell trafficking: a new cause of disease?. Am J Med Genet 2000, 91:22-28.
4. Khosrotehrani K., Johnson K.L., Cha D.H., Salomon R.N., Bianchi D.W. Transfer of fetal cells with multilineage potential to maternal tissue. JAMA 2004, 292:75-80.
5. Johnson K.L., Samura O., Nelson J.L., McDonnell MdWM, Bianchi D.W. Significant fetal cell microchimerism in a nontransfused woman with hepatitis C: evidence of long-term survival and expansion. Hepatology 2002, 36:1295-1297.
6. Vervoordeldonk S.F., Doumaid K., Remmerswaal E.B., ten Berge I.J., Wilmink J.M., de Waal L.P., et al. Long-term detection of microchimaerism in peripheral blood after pretransplantation blood transfusion. Br J Haematol 1998, 102:1004-1009.
7. Lapierre V., Auperin A., Robinet E., Ferrand C., Oubouzar N., Tramalloni D., et al. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study. Transfusion 2007, 47:1691-1699.
8. Willer C.J., Sadovnick A.D., Ebers G.C. Microchimerism in autoimmunity and transplantation: potential relevance to multiple sclerosis. J Neuroimmunol 2002, 126:126-133.
9. Rust D.W., Bianchi D.W. Microchimerism in endocrine pathology. Endocr Pathol 2009, 20:11-16.
10. Utter G.H., Lee T.H., Rivers R.M., Montalvo L., Wen L., Chafets D.M., et al. Microchimerism decades after transfusion among combat-injured US veterans from the Vietnam, Korean, and World War II conflicts. Transfusion 2008, 48:1609-1615.
11. Mold J.E., Michaelsson J., Burt T.D., Muench M.O., Beckerman K.P., Busch M.P., et al. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science 2008, 322:1562-1565.
12. Starzl T.E., Demetris A.J., Murase N., Trucco M., Thomson A.W., Rao A.S., et al. Chimerism after organ transplantation. Curr Opin Nephrol Hypertens 1997, 6:292-298.
13. Ariga H., Ohto H., Busch M.P., Imamura S., Watson R., Reed W., et al. Kinetics of fetal cellular and cell-free DNA in the maternal circulation during and after pregnancy: implications for noninvasive prenatal diagnosis. Transfusion 2001, 41:1524-1530.
14. Bianchi D.W., Robert E. Gross lecture. Fetomaternal cell trafficking: a story that begins with prenatal diagnosis and may end with stem cell therapy. J Pediatr Surg 2007, 42:12-18.
15. Owen R. Immunogenetic consequences of vascular anastomoses between bovine twins. Science 1945, 28:400-401.
16. van Dijk B.A., Boomsma D.I., de Man A.J. Blood group chimerism in human multiple births is not rare. Am J Med Genet 1996, 61:264-268.
17. Yan Z., Lambert N.C., Guthrie K.A., Porter A.J., Loubiere L.S., Madeleine M.M., et al. Male microchimerism in women without sons: quantitative assessment and correlation with pregnancy history. Am J Med 2005, 118:899-906.
18. Bloch E.M., Reed W.F., Lee T.H., Montalvo L., Shiboski S., Custer B., et al. Male microchimerism in peripheral blood leukocytes from women with multiple sclerosis. Chimerism 2011, 2:6-10.
19. Lambert N.C., Pang J.M., Yan Z., Erickson T.D., Stevens A.M., Furst D.E., et al. Male microchimerism in women with systemic sclerosis and healthy women who have never given birth to a son. Ann Rheum Dis 2005, 64:845-848.
20. Wang X., Chen C., Wang L., Chen D., Guang W., French J. Conception, early pregnancy loss, and time to clinical pregnancy: a population-based prospective study. Fertil Steril 2003, 79:577-584.
21. de Bellefon L.M., Heiman P., Kanaan S.B., Azzouz D.F., Rak J.M., Martin M., et al. Cells from a vanished twin as a source of microchimerism 40 years later. Chimerism 2010, 1:56-60.
22. Khosrotehrani K., Bianchi D.W. Multi-lineage potential of fetal cells in maternal tissue: a legacy in reverse. J Cell Sci 2005, 118:1559-1563.
23. Gammill H.S., Guthrie K.A., Aydelotte T.M., Waldorf K.M., Nelson J.L. Effect of parity on fetal and maternal microchimerism: interaction of grafts within a host?. Blood 2010, 116:2706-2712.
24. Schechter G.P., Whang-Peng J., McFarland W. Circulation of donor lymphocytes after blood transfusion in man. Blood 1977, 49:651-656.
25. Adams P.T., Davenport R.D., Reardon D.A., Roth M.S. Detection of circulating donor white blood cells in patients receiving multiple transfusions. Blood 1992, 80:551-555.
26. Lee T.H., Paglieroni T., Ohto H., Holland P.V., Busch M.P. Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients: frequent long-term microchimerism in severe trauma patients. Blood 1999, 93:3127-3139.
27. Dunne J.R., Lee T.H., Burns C., Cardo L.J., Curry K., Busch M.P. Transfusion-associated microchimerism in combat casualties. J Trauma 2008, 64:S92-S97. discussion S7-8.
28. Reed W., Lee T.H., Norris P.J., Utter G.H., Busch M.P. Transfusion-associated microchimerism: a new complication of blood transfusions in severely injured patients. Semin Hematol 2007, 44:24-31.
29. Utter G.H., Owings J.T., Lee T.H., Paglieroni T.G., Reed W.F., Gosselin R.C., et al. Microchimerism in transfused trauma patients is associated with diminished donor-specific lymphocyte response. J Trauma 2005, 58:925-931. discussion 31-2.
30. Utter G.H., Owings J.T., Lee T.H., Paglieroni T.G., Reed W.F., Gosselin R.C., et al. Blood transfusion is associated with donor leukocyte microchimerism in trauma patients. J Trauma 2004, 57:702-707. discussion 7-8.
31. Utter G.H., Nathens A.B., Lee T.H., Reed W., Owings J.T., Nester T., et al. Leukoreduction of blood transfusions does not diminish transfusion-associated microchimerism in transfused trauma patients. Transfusion 2006, 46:1863-1869.
32. Kruskall M.S., Lee T.H., Assmann S.F., Laycock M., Kalish L.A., Lederman M.M., et al. Survival of transfused donor white blood cells in HIV-infected recipients. Blood 2001, 98:272-279.
33. Reed W., Lee T.H., Vichinsky E.P., Lubin B.H., Busch M.P. Sample suitability for the detection of minor white cell populations (microchimerism) by polymerase chain reaction. Transfusion 1998, 38:1041-1045.
34. Sanchez R., Lee T.H., Wen L., Montalvo L., Schechterly C., Colvin C., et al. Absence of transfusion-associated microchimerism in pediatric and adult recipients of leukoreduced and gamma-irradiated blood components. Transfusion 2011, 52:936-945.
35. Bloch E.M., Busch M.P., Lee T.-H., Montalvo L., Bird A., Mathews Y., et al. Microchimerism in the transfused obstetric population (abstract). 32nd International Congress of the ISBT 2012 2012.
36. Gill R.M., Lee T.H., Utter G.H., Reed W.F., Wen L., Chafets D., et al. The TNF (-308A) polymorphism is associated with microchimerism in transfused trauma patients. Blood 2008, 111:3880-3883.
37. Stevens A.M., McDonnell W.M., Mullarkey M.E., Pang J.M., Leisenring W., Nelson J.L. Liver biopsies from human females contain male hepatocytes in the absence of transplantation. Lab Invest 2004, 84:1603-1609.
38. Vietor H.E., Hallensleben E., van Bree S.P., van der Meer E.M., Kaal S.E., Bennebroek-Gravenhorst J., et al. Survival of donor cells 25 years after intrauterine transfusion. Blood 2000, 95:2709-2714.
39. Flesland O., Ip L.S., Storlien A.S., Spurkland A., Larsen J., Solheim B.G. Microchimerism in immune competent patients related to the leukocyte content of transfused red blood cell concentrates. Transfus Apher Sci 2004, 31:173-180.
40. Nathens A.B., Nester T.A., Rubenfeld G.D., Nirula R., Gernsheimer T.B. The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock 2006, 26:342-347.
41. Lee T.H., Paglieroni T., Utter G.H., Chafets D., Gosselin R.C., Reed W., et al. High-level long-term white blood cell microchimerism after transfusion of leukoreduced blood components to patients resuscitated after severe traumatic injury. Transfusion 2005, 45:1280-1290.
42. Foex B.A., Lamb W.R., Roberts T.E., Brear S.G., Macartney I., Hammer M., et al. Early cytokine response to multiple injury. Injury 1993, 24:373-376.
43. Mimasaka S., Funayama M., Hashiyada M., Nata M., Tsunenari S. Significance of levels of IL-6 and IL-8 after trauma: a study of 11 cytokines post-mortem using multiplex immunoassay. Injury 2007, 38:1047-1051.
44. Partrick DA, Moore FA, Moore EE, Biffl WL, Sauaia A, Barnett CC, Jr. Jack A. Barney Resident Research Award winner. The inflammatory profile of interleukin-6, interleukin-8, and soluble intercellular adhesion molecule-1 in postinjury multiple organ failure. American journal of surgery 1996;172:425-9; [discussed 9-31].
45. Martin C., Boisson C., Haccoun M., Thomachot L., Mege J.L. Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma. Crit Care Med 1997, 25:1813-1819.
46. Endo S., Inada K., Yamada Y., Takakuwa T., Kasai T., Nakae H., et al. Plasma endotoxin and cytokine concentrations in patients with hemorrhagic shock. Crit Care Med 1994, 22:949-955.
47. Ferguson K.L., Taheri P., Rodriguez J., Tonapi V., Cardellio A., Dechert R. Tumor necrosis factor activity increases in the early response to trauma. Acad Emerg Med 1997, 4:1035-1040.
48. Hoch R.C., Rodriguez R., Manning T., Bishop M., Mead P., Shoemaker W.C., et al. Effects of accidental trauma on cytokine and endotoxin production. Crit Care Med 1993, 21:839-845.
49. Biffl W.L., Moore E.E., Moore F.A., Peterson V.M. Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation?. Ann Surg 1996, 224:647-664.
50. Giannoudis P.V., Smith R.M., Perry S.L., Windsor A.J., Dickson R.A., Bellamy M.C. Immediate IL-10 expression following major orthopaedic trauma: relationship to anti-inflammatory response and subsequent development of sepsis. Intensive Care Med 2000, 26:1076-1081.
51. Rabinovici R., John R., Esser K.M., Vernick J., Feuerstein G. Serum tumor necrosis factor-alpha profile in trauma patients. J Trauma 1993, 35:698-702.
52. Roumen R.M., Hendriks T., van der Ven-Jongekrijg J., Nieuwenhuijzen G.A., Sauerwein R.W., van der Meer J.W., et al. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg 1993, 218:769-776.
53. Seekamp A., Jochum M., Ziegler M., van Griensven M., Martin M., Regel G. Cytokines and adhesion molecules in elective and accidental trauma-related ischemia/reperfusion. J Trauma 1998, 44:874-882.
54. Sherry RM, Cue JI, Goddard JK, Parramore JB, DiPiro JT. Interleukin-10 is associated with the development of sepsis in trauma patients. J Trauma 1996;40:613-6; discussion 6-7.
55. DiPiro JT, Howdieshell TR, Goddard JK, Callaway DB, Hamilton RG, Mansberger AR, Jr. Association of interleukin-4 plasma levels with traumatic injury and clinical course. Arch Surg 1995;130:1159-62; [discussion 62-3].
56. DiPiro JT, Hamilton RG, Howdieshell TR, Adkinson NF, Jr., Mansberger AR, Jr. Total IgE in plasma is elevated after traumatic injury and is associated with sepsis syndrome. Ann Surg 1992;215:460-5; [discussion 5-6].
57. Bjornson A.B., Altemeier W.A., Bjornson H.S., Tang T., Iserson M.L. Host defense against opportunist microorganisms following trauma. I. Studies to determine the association between changes in humoral components of host defense and septicemia in burned patients. Ann Surg 1978, 188:93-101.
58. Faist E., Kupper T.S., Baker C.C., Chaudry I.H., Dwyer J., Baue A.E. Depression of cellular immunity after major injury. Its association with posttraumatic complications and its reversal with immunomodulation. Arch Surg 1986, 121:1000-1005.
59. O'Mahony J.B., Palder S.B., Wood J.J., McIrvine A., Rodrick M.L., Demling R.H., et al. Depression of cellular immunity after multiple trauma in the absence of sepsis. J Trauma 1984, 24:869-875.
60. Keane R.M., Birmingham W., Shatney C.M., Winchurch R.A., Munster A.M. Prediction of sepsis in the multitraumatic patient by assays of lymphocyte responsiveness. Surg Gynecol Obstet 1983, 156:163-167.
61. Livingston D.H., Appel S.H., Wellhausen S.R., Sonnenfeld G., Polk H.C. Depressed interferon gamma production and monocyte HLA-DR expression after severe injury. Arch Surg 1988, 123:1309-1312.
62. Szabo G., Kodys K., Miller-Graziano C.L. Elevated monocyte interleukin-6 (IL-6) production in immunosppressed trauma patients. II. Downregulation by IL-4. J Clin Immunol 1991, 11:336-344.
63. Faist E, Schinkel C, Zimmer S, Kremer JP, Von Donnersmarck GH, Schildberg FW. Inadequate interleukin-2 synthesis and interleukin-2 messenger expression following thermal and mechanical trauma in humans is caused by defective transmembrane signalling. J Trauma 1993;34:846-53; [discussion 53-4].
64. Lyons A, Kelly JL, Rodrick ML, Mannick JA, Lederer JA. Major injury induces increased production of interleukin-10 by cells of the immune system with a negative impact on resistance to infection. Ann Surg 1997;226:450-8; discussion 8-60.
65. + T regulatory cell activity in trauma patients depresses protective Th1 immunity. Ann Surg 2006, 244:514-523.
66. Xiao W., Mindrinos M.N., Seok J., Cuschieri J., Cuenca A.G., Gao H., et al. A genomic storm in critically injured humans. J Exp Med 2011, 208:2581-2590.
67. + regulatory T cells control innate immune reactivity after injury. J Immunol 2005, 174:2957-2963.
68. Kelly J.L., Lyons A., Soberg C.C., Mannick J.A., Lederer J.A. Anti-interleukin-10 antibody restores burn-induced defects in T-cell function. Surgery 1997, 122:146-152.
69. Ni Choileain N, MacConmara M, Zang Y, Murphy TJ, Mannick JA, Lederer JA. Enhanced regulatory T cell activity is an element of the host response to injury. J Immunol 2006;176:225-36.
70. Hsieh C.H., Frink M., Hsieh Y.C., Kan W.H., Hsu J.T., Schwacha M.G., et al. The role of MIP-1 alpha in the development of systemic inflammatory response and organ injury following trauma hemorrhage. J Immunol 2008, 181:2806-2812.
71. Kawasaki T., Fujimi S., Lederer J.A., Hubbard W.J., Choudhry M.A., Schwacha M.G., et al. Trauma-hemorrhage induces depressed splenic dendritic cell functions in mice. J Immunol 2006, 177:4514-4520.
72. Kobbe P., Vodovotz Y., Kaczorowski D.J., Mollen K.P., Billiar T.R., Pape H.C. Patterns of cytokine release and evolution of remote organ dysfunction after bilateral femur fracture. Shock 2008, 30:43-47.
73. Mack VE, McCarter MD, Naama HA, Calvano SE, Daly JM. Dominance of T-helper 2-type cytokines after severe injury. Arch Surg 1996;131:1303-8; [discussion 8-9].
74. Kang S.C., Matsutani T., Choudhry M.A., Schwacha M.G., Rue L.W., Bland K.I., et al. Are the immune responses different in middle-aged and young mice following bone fracture, tissue trauma and hemorrhage?. Cytokine 2004, 26:223-230.
75. Wichmann M.W., Ayala A., Chaudry I.H. Severe depression of host immune functions following closed-bone fracture, soft-tissue trauma, and hemorrhagic shock. Crit Care Med 1998, 26:1372-1378.
76. Basu S., Binder R.J., Suto R., Anderson K.M., Srivastava P.K. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int Immunol 2000, 12:1539-1546.
77. Rovere-Querini P., Capobianco A., Scaffidi P., Valentinis B., Catalanotti F., Giazzon M., et al. HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep 2004, 5:825-830.
78. Zhang Q., Raoof M., Chen Y., Sumi Y., Sursal T., Junger W., et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010, 464:104-107.
79. Roumen R.M., Hendriks T., Wevers R.A., Goris J.A. Intestinal permeability after severe trauma and hemorrhagic shock is increased without relation to septic complications. Arch Surg 1993, 128:453-457.
80. Rush B.F., Sori A.J., Murphy T.F., Smith S., Flanagan J.J., Machiedo G.W. Endotoxemia and bacteremia during hemorrhagic shock. The link between trauma and sepsis?. Ann Surg 1988, 207:549-554.
81. Abraham E., Chang Y.H. Cellular and humoral bases of hemorrhage-induced depression of lymphocyte function. Crit Care Med 1986, 14:81-86.
82. Abraham E., Freitas A.A. Hemorrhage produces abnormalities in lymphocyte function and lymphokine generation. J Immunol 1989, 142:899-906.
83. Stephan R.N., Kupper T.S., Geha A.S., Baue A.E., Chaudry I.H. Hemorrhage without tissue trauma produces immunosuppression and enhances susceptibility to sepsis. Arch Surg 1987, 122:62-68.
84. van der Poll T., Coyle S.M., Barbosa K., Braxton C.C., Lowry S.F. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J Clin Invest 1996, 97:713-719.
85. Woiciechowsky C., Asadullah K., Nestler D., Eberhardt B., Platzer C., Schoning B., et al. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat Med 1998, 4:808-813.
86. Hasko G., Szabo C., Nemeth Z.H., Deitch E.A. Dopamine suppresses IL-12 p40 production by lipopolysaccharide-stimulated macrophages via a beta-adrenoceptor-mediated mechanism. J Neuroimmunol 2002, 122:34-39.
87. Madden K.S., Sanders V.M., Felten D.L. Catecholamine influences and sympathetic neural modulation of immune responsiveness. Annu Rev Pharmacol Toxicol 1995, 35:417-448.
88. Severn A., Rapson N.T., Hunter C.A., Liew F.Y. Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists. J Immunol 1992, 148:3441-3445.
89. Barton R.N., Cocks R.A., Doyle M.O., Chambers H. Time course of the early pituitary-adrenal and metabolic responses to accidental injury. J Trauma 1995, 39:888-894.
90. Barton R.N., Stoner H.B., Watson S.M. Relationships among plasma cortisol, adrenocorticotrophin, and severity of injury in recently injured patients. J Trauma 1987, 27:384-392.
91. Schrader K.A. Stress and immunity after traumatic injury: the mind-body link. AACN Clin Issues 1996, 7:351-358.
92. Stoner H.B., Frayn K.N., Barton R.N., Threlfall C.J., Little R.A. The relationships between plasma substrates and hormones and the severity of injury in 277 recently injured patients. Clin Sci (Lond) 1979, 56:563-573.
93. Woolf P.D. Hormonal responses to trauma. Crit Care Med 1992, 20:216-226.
94. Morris J.A., MacKenzie E.J., Damiano A.M., Bass S.M. Mortality in trauma patients: the interaction between host factors and severity. J Trauma 1990, 30:1476-1482.
95. Oberholzer A., Keel M., Zellweger R., Steckholzer U., Trentz O., Ertel W. Incidence of septic complications and multiple organ failure in severely injured patients is sex specific. J Trauma 2000, 48:932-937.
96. Schroder J., Kahlke V., Staubach K.H., Zabel P., Stuber F. Gender differences in human sepsis. Arch Surg 1998, 133:1200-1205.
97. Wichmann M.W., Inthorn D., Andress H.J., Schildberg F.W. Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome. Intensive Care Med 2000, 26:167-172.
98. Wohltmann C.D., Franklin G.A., Boaz P.W., Luchette F.A., Kearney P.A., Richardson J.D., et al. A multicenter evaluation of whether gender dimorphism affects survival after trauma. Am J Surg 2001, 181:297-300.
99. Choudhry M.A., Bland K.I., Chaudry I.H. Trauma and immune response-effect of gender differences. Injury 2007, 38:1382-1391.
100. Yokoyama Y., Schwacha M.G., Samy T.S., Bland K.I., Chaudry I.H. Gender dimorphism in immune responses following trauma and hemorrhage. Immunol Res 2002, 26:63-76.
101. Opelz G., Vanrenterghem Y., Kirste G., Gray D.W., Horsburgh T., Lachance J.G., et al. Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients. Transplantation 1997, 63:964-967.
102. Opelz G., Sengar D.P., Mickey M.R., Terasaki P.I. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973, 5:253-259.
103. Opelz G., Terasaki P.I. Prolongation effect of blood transfusions on kidney graft survival. Transplantation 1976, 22:380-383.
104. Vamvakas E.C., Blajchman M.A. Transfusion-related immunomodulation (TRIM): an update. Blood Rev 2007, 21:327-348.
105. Okuno K., Ozaki M., Shigeoka H., Nakajima I., Nakamura K., Hirohata T., et al. Effect of packed red cell and whole blood transfusion on liver-associated immune function. Am J Surg 1994, 168:340-344.
106. Pirenne J., Kitade H., Kawai M., Koshiba T., Van Damme B., Mathieu C., et al. Regulatory cells, TH1/TH2 unbalance, and antibody-induced chronic rejection in operational tolerance induced by donor-specific blood transfusion. Transplantation 2005, 79:S25-S27.
107. Salvatierra O., Vincenti F., Amend W., Potter D., Iwaki Y., Opelz G., et al. Deliberate donor-specific blood transfusions prior to living related renal transplantation. A new approach. Ann Surg 1980, 192:543-552.
108. Singal D.P., Joseph S. Role of blood transfusions on the induction of antibodies against recognition sites on T lymphocytes in renal transplant patients. Hum Immunol 1982, 4:93-108.
109. Burrows L., Tartter P., Aufses A. Increased recurrence rates in perioperatively transfused colorectal malignancy patients. Cancer Detect Prev 1987, 10:361-369.
110. Dutcher J.P., Schiffer C.A., Aisner J., Wiernik P.H. Alloimmunization following platelet transfusion: the absence of a dose-response relationship. Blood 1981, 57:395-398.
111. Fauchet R., Genetet B., Gueguen M., Leguerrier A., Rioux C., Logeais Y. Transfusion therapy and HLA antibody response in patients undergoing open heart surgery. Transfusion 1982, 22:320-322.
112. Howard J.E., Perkins H.A. The natural history of alloimmunization to platelets. Transfusion 1978, 18:496-503.
113. Heddle N.M., Soutar R.L., O'Hoski P.L., Singer J., McBride J.A., Ali M.A., et al. A prospective study to determine the frequency and clinical significance of alloimmunization post-transfusion. Br J Haematol 1995, 91:1000-1005.
114. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. The Trial to Reduce Alloimmunization to Platelets Study Group. N Engl J Med 1997, 337:1861-1869.
115. Desmarets M., Cadwell C.M., Peterson K.R., Neades R., Zimring J.C. Minor histocompatibility antigens on transfused leukoreduced units of red blood cells induce bone marrow transplant rejection in a mouse model. Blood 2009, 114:2315-2322.
116. Kissmeyer-Nielsen F., Olsen S., Petersen V.P., Fjeldborg O. Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet 1966, 2:662-665.
117. Giannoudis P.V. Current concepts of the inflammatory response after major trauma: an update. Injury 2003, 34:397-404.
118. Mannick J.A., Rodrick M.L., Lederer J.A. The immunologic response to injury. J Am Coll Surg 2001, 193:237-244.
119. Moore F.A., Sauaia A., Moore E.E., Haenel J.B., Burch J.M., Lezotte D.C. Postinjury multiple organ failure: a bimodal phenomenon. J Trauma 1996, 40:501-510. [discussion 10-2].
120. Jackman R.P., Utter G.H., Muench M.O., Heitman J.W., Munz M.M., Jackman R.W., et al. Distinct roles of trauma and transfusion in induction of immune modulation after injury. Transfusion 2012.
121. Klintschar M., Immel U.D., Kehlen A., Schwaiger P., Mustafa T., Mannweiler S., et al. Fetal microchimerism in Hashimoto's thyroiditis: a quantitative approach. Eur J Endocrinol 2006, 154:237-241.
122. Bianchi D.W. From Michael to microarrays: 30 years of studying fetal cells and nucleic acids in maternal blood. Prenat Diagn 2010, 30:622-623.
123. Lee T.H., Donegan E., Slichter S., Busch M.P. Transient increase in circulating donor leukocytes after allogeneic transfusions in immunocompetent recipients compatible with donor cell proliferation. Blood 1995, 85:1207-1214.
124. Lee T.-H., Donegan E., Slichter S., Busch M. Transient increase in circulating donor leukocytes after allogeneic transfusion in immunocompetent recipients compatible with donor cell proliferation. Blood 1995, 85:1207-1214.
125. Reed W.F., Lee T.L., Trachtenberg E., Vinson M., Busch M.P. Detection of microchimerism by PCR is a function of amplification strategy. Transfusion 2001, 41:39-44.
126. Reed W., Kong D.Z., Lee T.H., Cowan M.J., Busch M.P., Baxter-Lowe L.A. Non-invasive determination of the paternal HLA haplotype of a fetus using kinetic PCR to detect fetal microchimerism in maternal plasma. Bone Marrow Transplant 2002, 29:527-529.
127. Lee T.H., Reed W., Mangawang-Montalvo L., Watson J., Busch M.P. Donor WBCs can persist and transiently mediate immunologic function in a murine transfusion model: effects of irradiation, storage, and histocompatibility. Transfusion 2001, 41:637-642.
128. Carrier E., Lee T.H., Busch M.P., Cowan M.J. Induction of tolerance in nondefective mice after in utero transplantation of major histocompatibility complex-mismatched fetal hematopoietic stem cells. Blood 1995, 86:4681-4690.
129. Carrier E., Lee T.H., Busch M.P., Cowan M.J. Recruitment of engrafted donor cells postnatally into the blood with cytokines after in utero transplantation in mice. Transplantation 1997, 64:627-633.
130. Carrier E., Gilpin E., Lee T.H., Busch M.P., Zanetti M. Microchimerism does not induce tolerance after in utero transplantation and may lead to the development of alloreactivity. J Lab Clin Med 2000, 136:224-235.
131. Chou S.H., Chawla A., Lee T.H., Zhou Y., Busch M.P., Balassanian R., et al. Increased engraftment and GVHD after in utero transplantation of MHC-mismatched bone marrow cells and CD80low, CD86(-) dendritic cells in a fetal mouse model. Transplantation 2001, 72:1768-1776.
132. Donahue J., Gilpin E., Lee T.H., Busch M.P., Croft M., Carrier E. Microchimerism does not induce tolerance and sustains immunity after in utero transplantation. Transplantation 2001, 71:359-368.
133. Malinen E., Kassinen A., Rinttila T., Palva A. Comparison of real-time PCR with SYBR Green I or 5'-nuclease assays and dot-blot hybridization with rDNA-targeted oligonucleotide probes in quantification of selected faecal bacteria. Microbiology 2003, 149:269-277.
134. Maeda H., Fujimoto C., Haruki Y., Maeda T., Kokeguchi S., Petelin M., et al. Quantitative real-time PCR using TaqMan and SYBR Green for Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, Prevotella intermedia, tetQ gene and total bacteria. FEMS Immunol Med Microbiol 2003, 39:81-86.
135. Schmittgen T.D., Zakrajsek B.A., Mills A.G., Gorn V., Singer M.J., Reed M.W. Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods. Anal Biochem 2000, 285:194-204.
136. Alizadeh M., Bernard M., Danic B., Dauriac C., Birebent B., Lapart C., et al. Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction. Blood 2002, 99:4618-4625.
137. Lee T.-H., Chafets D., Reed W., Wen L., Yang Y., Chen J., et al. Enhanced ascertainment of microchimerism with real-time quantitative PCR amplification of insertion/deletion polymorphisms. Transfusion 2006, 46:1870-1878.
138. Willer C.J., Herrera B.M., Morrison K.M., Sadovnick A.D., Ebers G.C. Association between microchimerism and multiple sclerosis in Canadian twins. J Neuroimmunol 2006.
139. Aractingi S., Berkane N., Bertheau P., Le Goue C., Dausset J., Uzan S., et al. Fetal DNA in skin of polymorphic eruptions of pregnancy. Lancet 1998, 352:1898-1901.
140. Klintschar M., Schwaiger P., Mannweiler S., Regauer S., Kleiber M. Evidence of fetal microchimerism in Hashimoto's thyroiditis. J Clin Endocrinol Metab 2001, 86:2494-2498.
141. Suskind D.L., Rosenthal P., Heyman M.B., Kong D., Magrane G., Baxter-Lowe L.A., et al. Maternal microchimerism in the livers of patients with biliary atresia. BMC Gastroenterol 2004, 4:14.
142. Hayashida M., Nishimoto Y., Matsuura T., Takahashi Y., Kohashi K., Souzaki R., et al. The evidence of maternal microchimerism in biliary atresia using fluorescent in situ hybridization. J Pediatr Surg 2007, 42:2097-2101.
143. Nelson J.L. Maternal-fetal immunology and autoimmune disease: is some autoimmune disease auto-alloimmune or allo-autoimmune?. Arthritis Rheum 1996, 39:191-194.
144. Nelson J.L. Microchimerism and autoimmune disease. N Engl J Med 1998, 338:1224-1225.
145. Dwyre D.M., Holland P.V. Transfusion-associated graft-versus-host disease. Vox Sang 2008, 95:85-93.
146. Sakurai M., Moizumi Y., Uchida S., Imai Y., Tabayashi K. Transfusion-associated graft-versus-host disease in immunocompetent patient: early diagnosis and therapy. Am J Hematol 1998, 58:84-86.
147. Reid M.E., Rios M., Powell V.I., Charles-Pierre D., Malavade V. DNA from blood samples can be used to genotype patients who have recently received a transfusion. Transfusion 2000, 40:48-53.
148. Kremer Hovinga I.C., Koopmans M., Baelde H.J., de Heer E., Bruijn J.A., Bajema I.M. Tissue chimerism in systemic lupus erythematosus is related to injury. Ann Rheum Dis 2007, 66:1568-1573.
149. Kremer Hovinga I.C., Koopmans M., de Heer E., Bruijn J.A., Bajema I.M. Chimerism in systemic lupus erythematosus-three hypotheses. Rheumatology (Oxford) 2007, 46:200-208.
150. Bianchi D.W., Simpson J.L., Jackson L.G., Elias S., Holzgreve W., Evans M.I., et al. Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. Prenat Diagn 2002, 22:609-615.